Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT06374277

Pharmacy-led Transitions of Care Intervention to Improve Medication Adherence

Led by University of Tennessee · Updated on 2026-01-29

388

Participants Needed

2

Research Sites

199 weeks

Total Duration

On this page

Sponsors

U

University of Tennessee

Lead Sponsor

S

Sponsor GmbH

Collaborating Sponsor

AI-Summary

What this Trial Is About

Socioeconomically disadvantaged populations with multiple chronic conditions have high rates of nonadherence to essential chronic disease medications after hospital discharge. Medication nonadherence after hospital discharge is significantly associated with increased mortality and higher rates of readmissions and costs among these patients. Major patient-reported barriers to essential medication use after hospital discharge among low-income individuals are related to social determinants of health (SDOH) and include: 1) financial barriers , 2) transportation barriers, and 3) system-level barriers. Although, medication therapy management services are important during care transitions, these services have not proven effective in improving medication adherence after hospital discharge, highlighting a critical need for innovative interventions. The Medication Affordability, Accessibility, and Availability in Care Transitions (Med AAAction) Study will test the effectiveness of a pharmacy-led care transitions intervention versus usual care through a pragmatic randomized controlled trial of 388 Medicaid and uninsured hospital in-patients with MCC from three large healthcare systems in Tennessee. The intervention will involve: 1) medications with zero copay, 2) bedside delivery then home delivery of medications, and 3) care coordination provided by certified pharmacy technicians/health coaches to assist with medication access, medication reconciliation, and rapid and ongoing primary care follow-up. We will examine the impact of the intervention during 12 months on 1) medication adherence (primary outcome) and 2) rapid primary care follow-up, 30-day readmissions, hospitalizations and emergency department visits, and costs. We will conduct key informant interviews to understand patient experience with the acre received during and after care transitions. By examining effectiveness of the intervention on outcomes including medication adherence, health care utilization, costs, and patient experience, this study will provide valuable results to health systems, payers, and policymakers to assist in future implementation and sustainability of the intervention for socioeconomically disadvantaged populations.

CONDITIONS

Official Title

Pharmacy-led Transitions of Care Intervention to Improve Medication Adherence

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Medicaid or uninsured inpatients
  • 21 years or older
  • Two or more complex chronic conditions during index admission or prescribed/using two or more chronic medications for these conditions
  • Receiving chronic disease medications from the hospital pharmacy
  • Diagnosed with conditions including diabetes, hypertension, high cholesterol, coronary artery disease, congestive heart failure, chronic lung disease, chronic kidney disease, arrhythmia, stroke, depression, anxiety, or prescribed anticoagulants
Not Eligible

You will not qualify if you...

  • Medicare and Medicaid dual eligible patients
  • Primary reason for admission related to cancer, pregnancy, or an acute surgical procedure
  • Diagnosed with active psychosis, substance abuse, or suicidal ideation during admission
  • Planned discharge location is not home
  • Participation in an existing pharmacy discharge program

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

University of Tennessee Medical Center

Knoxville, Tennessee, United States, 37920

Not Yet Recruiting

2

University of Tennessee Health Science Center/Regional One Health

Memphis, Tennessee, United States, 38103

Actively Recruiting

Loading map...

Research Team

S

Satya Surbhi, PhD

CONTACT

E

Elizabeth A Tolley, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

HEALTH_SERVICES_RESEARCH

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here